Purpose Observe the clinical efficacy of Iron dextran dispersible tables with Iysine and Vitamine B12 Granules to treat the children with nutritional anemia.
目的观察右旋糖酐铁分散片联合赖氨酸b12颗粒用药治疗小儿营养性贫血的临床疗效。
The average molecular weight and molecular weight distribution were determined with acid hydrolyzed iron dextran samples.
样品经酸水解，测得右旋糖酐铁中右旋糖酐的重均分子量和分子量分布。
Objective to establish an optimal method to determine the contents of Fe and dextran in the nanometer iron compound.
目的建立适用于纳米铁包合物中铁及右旋糖酐含量测定的方法。
All of above show that dextran iron can control piglets anaemia effectively.
表明葡聚糖酐铁对仔猪贫血有良好的防治效果。
The proposed method was applied to determine the iron dextran injection with satisfactory results.
采用分光光度法对右旋糖酐铁注射液进行了含量测定，结果令人满意。
Conclusion:Intravenous therapy with iron dextran injection can quickly improve anemia in patients with hemodialysis, raise iron availability and therapeutic efficacy of rHuEPO.
结论：静脉注射右旋糖酐氢氧化铁可有效纠正维持性血透患者的铁缺乏、提高铁利用率及重组红细胞生成素的治疗效果。
Conclusion Iron dextran treatment in RLS on hemodialysis patients effective.
结论右旋糖酐铁治疗维持性血液透析并rls有效。
Objective to investigate the curative effect and untoward effect of intravenous therapy with iron dextran for renal anemia induced by uremia.
目的观察右旋糖酐铁静脉注射治疗尿毒症致肾性贫血的疗效和不良反应。
The iron dextran was used only in the iron agents for injection.
注射铁剂中，右旋糖酐铁注射液应用较多。
Objective To investigate the effect of preparation conditions on the effective diameter and saturation magnetization of dextran magnetic iron oxide nanoparticles.
目的探讨葡聚糖氧化铁磁性纳米颗粒的制备对其有效粒径和比饱和磁化强度的影响。
Methods:The dextran coated iron oxide nanoparticles (DCIONP) was synthesized with deposition.
方法：应用共沉淀法制备外包葡聚糖的氧化铁磁性纳米颗粒（DCIONP）。
There were no severe adverse events in both groups and 1 case suffered from muscular soreness in the lower limbs in iron dextran group.
两组患者均无严重不良反应发生，对照组有1例发生下肢肌肉酸痛。
Hermodialysis; Restless Legs Syndrome; Iron Dextran.
血液透析；不宁腿综合征；右旋糖酐铁。
Therefore, intravenous iron dextran has greater cost-effectiveness than oral iron in renal anemia, and is worthy to be recommended to clinical application.
结论静脉组与口服组比较治疗成本没有差别，疗效更好，静脉组治疗肾性贫血更具成本效果，值得临床推荐。
We are the leading supplier of pharmaceutical raw materials and intermediates in China. At present we can offer you Iron Dextran 10%, 20% Solution;
公司和产品介绍：我们主要经营化工医药原料及其中间体，我们目前的主要产品是右旋糖苷铁10％，20％溶液；
We are the leading supplier of pharmaceutical raw materials and intermediates in China. At present we can offer you Iron Dextran 10%, 20% Solution;
公司和产品介绍：我们主要经营化工医药原料及其中间体，我们目前的主要产品是右旋糖苷铁10％，20％溶液；
应用推荐